SCHEMBL12420928

SCHEMBL12420928

O=CCC(c1ccccc1)n1cnc2cc(NC(=O)c3ccccc3N=O)ccc21

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 13/20 0.41
RAB9A P51151 13/20 0.41
SMN1; SMN2 Q16637 8/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 4/20 0.38
TP53 P04637 3/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 1/20 0.38
POLB P06746 2/20 0.38
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
ADRA2B P18089 1/20 0.36
MEN1 O00255 1/20 0.36
NR1I2 O75469 1/20 0.36
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12421964 0.93 ALDH1A1 (0.36) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL12420299 0.87 FADS1 (0.44) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL12420933 0.84 MEN1 (0.44) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL12421967 0.83 NR1I2 (0.45) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL12420930 0.83 NR1I2 (0.45) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL12420935 0.82 ATM (0.43) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL12420191 0.82 KMT2A (0.50) ALDH1A1POLBKDM4EKMT2AGAA
SCHEMBL12420295 0.81 NPC1 (0.48) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL12420298 0.80 NPC1 (0.46) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL12420308 0.80 RAB9A (0.47) NPC1RAB9AALDH1A1HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003806-B2 Integrin antagonists useful as anticancer agents OSI Pharmaceuticals, LLC (US) 2011-08-23 US disclosed